(Q37559647)

21 August 2017

1 reference

title

Mucosal vaccines: novel advances in technology and delivery (English)

1 reference

21 August 2017

Yoshikazu Yuki

1

1 reference

PubMed ID

19627189

21 August 2017

Hiroshi Kiyono

series ordinal

2

1 reference

21 August 2017

1 August 2009

1 reference

Expert Review of Vaccines

21 August 2017

1 reference

21 August 2017

8

1 reference

21 August 2017

8

1 reference

21 August 2017

1083-1097

1 reference

Progress towards an AIDS mucosal vaccine: an overview

21 August 2017

1 reference

Mucosal immunity and vaccines

21 January 2018

1 reference

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

21 January 2018

1 reference

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

21 January 2018

1 reference

Mucosal immunity and tolerance: relevance to vaccine development

21 January 2018

1 reference

New generation of mucosal adjuvants for the induction of protective immunity

21 January 2018

1 reference

A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense

21 January 2018

1 reference

NALT- versus Peyer's-patch-mediated mucosal immunity

21 January 2018

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

21 January 2018

1 reference

Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.

21 January 2018

1 reference

Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

21 January 2018

1 reference

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

21 January 2018

1 reference

Retinoic acid imprints gut-homing specificity on T cells

21 January 2018

1 reference

Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells

21 January 2018

1 reference

Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system

21 January 2018

1 reference

Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses

21 January 2018

1 reference

The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces

21 January 2018

1 reference

Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins

21 January 2018

1 reference

Epithelial M cells: gateways for mucosal infection and immunization

21 January 2018

1 reference

21 January 2018

Mucosal dendritic cells

1 reference

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

21 January 2018

1 reference

Intestinal villous M cells: an antigen entry site in the mucosal epithelium

21 January 2018

1 reference

A review of vaccine research and development: human enteric infections

21 January 2018

1 reference

Vaccination against polio should not be stopped

21 January 2018

1 reference

Complexes of poliovirus serotypes with their common cellular receptor, CD155

21 January 2018

1 reference

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.

21 January 2018

1 reference

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

21 January 2018

1 reference

Live oral vaccines against cholera: an update.

21 January 2018

1 reference

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

21 January 2018

1 reference

Field trial of oral cholera vaccines in Bangladesh

21 January 2018

1 reference

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

21 January 2018

1 reference

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

21 January 2018

1 reference

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

21 January 2018

1 reference

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

21 January 2018

1 reference

Typhoid fever in children aged less than 5 years

21 January 2018

1 reference

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

21 January 2018

1 reference

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

21 January 2018

1 reference

Experience with registered mucosal vaccines

21 January 2018

1 reference

Rotavirus vaccines: entering a new stage of deployment.

21 January 2018

1 reference

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

21 January 2018

1 reference

Intussusception and rotavirus vaccines

21 January 2018

1 reference

Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception.

21 January 2018

1 reference

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

21 January 2018

1 reference

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

Immunity and correlates of protection for rotavirus vaccines

21 January 2018

1 reference

Burden of disease--implications for future research

21 January 2018

1 reference

A review of vaccine research and development: human acute respiratory infections.

21 January 2018

1 reference

Influenza and the rates of hospitalization for respiratory disease among infants and young children

21 January 2018

1 reference

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

21 January 2018

1 reference

Current status of live attenuated influenza virus vaccine in the US.

21 January 2018

1 reference

Adaptation and Growth Characteristics of Influenza Virus at 25° C

21 January 2018

1 reference

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

21 January 2018

1 reference

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys

21 January 2018

1 reference

Immunology of tuberculosis

21 January 2018

1 reference

Advances in tuberculosis vaccine strategies

21 January 2018

1 reference

Mucosal vaccination against bacterial respiratory infections

21 January 2018

1 reference

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

21 January 2018

1 reference

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

21 January 2018

1 reference

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

Needle-free vaccine delivery

21 January 2018

1 reference

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study.

21 January 2018

1 reference

21 January 2018

1 reference

The production of recombinant pharmaceutical proteins in plants.

21 January 2018

1 reference

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

21 January 2018

1 reference

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

21 January 2018

1 reference

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

21 January 2018

1 reference

The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces

21 January 2018

1 reference

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

21 January 2018

1 reference

M cell-targeted DNA vaccination

21 January 2018

1 reference

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

21 January 2018

1 reference

Safety of sublingual immunotherapy with a monomeric allergoid in very young children.

21 January 2018

1 reference

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

21 January 2018

1 reference

Sublingual vaccination with influenza virus protects mice against lethal viral infection

21 January 2018

1 reference

Toll-like receptors as adjuvant receptors

21 January 2018

1 reference

Public health. Grand Challenges in Global Health

21 January 2018

1 reference

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.61

1 reference

21 August 2017

1 reference

PubMed ID

19627189